{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:19:03Z","timestamp":1770509943470,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T00:00:00Z","timestamp":1487116800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s11655-017-2954-2","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T23:36:23Z","timestamp":1487115383000},"page":"185-192","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical Efficacy and Safety of Bathing with Chinese Medicine Taohong Siwu Decoction (\u6843\u7ea2\u56db\u7269\u6c64) for Treatment of Diffuse Cutaneous Systemic Sclerosis: A Randomized Placebo-Controlled Trial"],"prefix":"10.1007","volume":"24","author":[{"given":"Jing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue-shu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,15]]},"reference":[{"key":"2954_CR1","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","volume":"6","author":"D Pattanaik","year":"2015","unstructured":"Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE. Pathogenesis of systemic sclerosis. Front Immunol 2015;6:272.","journal-title":"Front Immunol"},{"key":"2954_CR2","first-page":"705","volume":"10","author":"M Sticherling","year":"2012","unstructured":"Sticherling M. Systemic sclerosis-dermatological aspects. Part 1: Pathogenesis, epidemiology, clinical findings. J Dtsch Dermatol Ges 2012;10:705\u2013718.","journal-title":"Part 1: Pathogenesis, epidemiology, clinical findings. J Dtsch Dermatol Ges"},{"key":"2954_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.5604\/17322693.1117543","volume":"68","author":"E Wielosz","year":"2014","unstructured":"Wielosz E, Dryglewska M, Majdan M. Serological profile of patients with systemic sclerosis. Postepy Hig Med Dosw (Online) 2014;68:987\u2013991.","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"2954_CR4","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10067-012-2145-7","volume":"32","author":"J Wang","year":"2013","unstructured":"Wang J, Assassi S, Guo G, Tu W, Wu W, Yang L, et al. Clinical and serological features of systemic sclerosis in a Chinese cohort. Clin Rheumatol 2013;32:617\u2013621.","journal-title":"Clin Rheumatol"},{"key":"2954_CR5","first-page":"S97","volume":"30","author":"L Chung","year":"2012","unstructured":"Chung L, Denton CP, Distler O, Furst DE, Khanna D, Merkel PA. Clinical trial design in scleroderma: where are we and where do we go next? Clin Exp Rheumatol 2012;30:S97\u2013S102.","journal-title":"Clin Exp Rheumatol"},{"key":"2954_CR6","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7","volume":"42","author":"PJ Clements","year":"1999","unstructured":"Clements PJ, Furst DE, Wong WK, Mayes M, White B, Wigley F, et al. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum 1999;42:1194\u20131203.","journal-title":"Arthritis Rheum"},{"key":"2954_CR7","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I","volume":"44","author":"JE Pope","year":"2001","unstructured":"Pope JE, Bellamy N, Seibold JR, Baron M, Ellman M, Carette S, et al. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Arthritis Rheum 2001;44:1351\u20131358.","journal-title":"Arthritis Rheum"},{"key":"2954_CR8","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/j.1365-2133.2012.11186.x","volume":"167","author":"S Prey","year":"2012","unstructured":"Prey S, Ezzedine K, Doussau A, Grandoulier AS, Barcat D, Chatelus E, et al. Imatinib mesylate in sclerodermaassociated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial. Br J Dermatol 2012;167:1138\u20131144.","journal-title":"Br J Dermatol"},{"key":"2954_CR9","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/art.24380","volume":"60","author":"D Khanna","year":"2009","unstructured":"Khanna D, Clements PJ, Furst DE, Korn JH, Ellman M, Rothfield N, et al. Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebocontrolled trial. Arthritis Rheum 2009;60:1102\u20131111.","journal-title":"Arthritis Rheum"},{"key":"2954_CR10","first-page":"1573","volume":"28","author":"EC LeRoy","year":"2001","unstructured":"LeRoy EC, Medsger TA, Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573\u20131576.","journal-title":"J Rheumatol"},{"key":"2954_CR11","first-page":"936","volume":"31","author":"D Zhao","year":"2014","unstructured":"Zhao D, Wang F. The study progress of TCM on systemic sclerosis. J Hubei Univ Nat (Chin) 2014;31:936\u2013938.","journal-title":"J Hubei Univ Nat (Chin)"},{"key":"2954_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/BF02835746","volume":"11","author":"WL Wang","year":"2005","unstructured":"Wang WL, Su YM, Yang RY, Zhang J, Xu Y. Followup efficacy of integrative Chinese and Western drugs on localized scleroderma with vitamine B6 and Xuefu Zhuyu Decoction. Chin J Integr Med 2005;11:34\u201336.","journal-title":"Chin J Integr Med"},{"key":"2954_CR13","first-page":"353","volume":"10","author":"XN Yan","year":"2011","unstructured":"Yan XN, Han SR, Li WB, Li MH, Liu YT. Effects of Refu Yao on mice models with scleroderma of COL-I and COL-III. Chin J Dermatovenerol Integr Tradit West Med (Chin) 2011;10:353\u2013355.","journal-title":"Chin J Dermatovenerol Integr Tradit West Med (Chin)"},{"key":"2954_CR14","first-page":"12","volume-title":"J Chengdu Univ Tradit Chin Med (Chin)","author":"L Wu","year":"2014","unstructured":"Wu L. Literature analysis of external treatment of traditional Chinese medicine (TCM) on scleroderma and exploration of drug laws. J Chengdu Univ Tradit Chin Med (Chin) 2014:12\u201336."},{"key":"2954_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12016-009-8193-3","volume":"40","author":"M Geyer","year":"2011","unstructured":"Geyer M, Muller-Ladner U. The pathogenesis of systemic sclerosis revisited. Clin Rev Allergy Immunol 2011;40:92\u2013103.","journal-title":"Clin Rev Allergy Immunol"},{"key":"2954_CR16","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737\u20132747.","journal-title":"Arthritis Rheum"},{"key":"2954_CR17","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/1756-185X.12165","volume":"18","author":"H Zhang","year":"2015","unstructured":"Zhang H, Liu T, Li F. A random, case-control study on the efficacy and safety of Weishi Bitong Xifang Fumigation for mild and moderate knee osteoarthritis patients. Int J Rheum Dis 2015;18:502\u2013507.","journal-title":"Int J Rheum Dis"},{"key":"2954_CR18","first-page":"1082","volume":"98","author":"C Foocharoen","year":"2015","unstructured":"Foocharoen C, Thinkhamrop B, Mahakkanukrauh A, Suwannaroj S, Netwijitpan S, Sripavatakul K, et al. Interand intra-observer reliability of modified Rodnan Skin Score assessment in thai systemic sclerosis patients: a validation for multicenter scleroderma cohort study. J Med Assoc Thai 2015;98:1082\u20131088.","journal-title":"J Med Assoc Thai"},{"key":"2954_CR19","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1093\/rheumatology\/kel038","volume":"45","author":"G Milio","year":"2006","unstructured":"Milio G, Corrado E, Genova C, Amato C, Raimondi F, Almasio PL, et al. Iloprost treatment in patients with Raynaud\u2019s phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol. Rheumatology (Oxford) 2006;45:999\u20131004.","journal-title":"Rheumatology (Oxford)"},{"key":"2954_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0248-8663(03)00268-6","volume":"25","author":"C Georges","year":"2004","unstructured":"Georges C, Chassany O, Mouthon L, Tiev K, Marjanovic Z, Meyer O, et al. Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis. Rev Med Intern 2004;25:16\u201321.","journal-title":"Rev Med Intern"},{"key":"2954_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1477-7525-11-23","volume":"11","author":"M Iudici","year":"2013","unstructured":"Iudici M, Cuomo G, Vettori S, Avellino M, Valentini G. Quality of life as measured by the short-form 36 (SF-36) questionnaire in patients with early systemic sclerosis and undifferentiated connective tissue disease. Health Qual Life Outcomes 2013;11:23.","journal-title":"Health Qual Life Outcomes"},{"key":"2954_CR22","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/art.24676","volume":"61","author":"M Hudson","year":"2009","unstructured":"Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M. Health-related quality of life in systemic sclerosis: a systematic review. Arthritis Rheum 2009;61:1112\u20131120.","journal-title":"Arthritis Rheum"},{"key":"2954_CR23","first-page":"832","volume":"32","author":"D Khanna","year":"2005","unstructured":"Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, et al. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol 2005;32:832\u2013840.","journal-title":"J Rheumatol"},{"key":"2954_CR24","volume-title":"Guiding principle of clinical research on new drugs of traditional Chinese medicine","author":"XY Zheng","year":"2002","unstructured":"Zheng XY, ed. Guiding principle of clinical research on new drugs of traditional Chinese medicine. Beijing: Chinese Medicine and Technology Publishing House; 2002."},{"key":"2954_CR25","first-page":"466","volume":"35","author":"D Khanna","year":"2008","unstructured":"Khanna D, Clements PJ, Postlethwaite AE, Furst DE. Does incorporation of aids and devices make a difference in the score of the health assessment questionnairedisability index? Analysis from a scleroderma clinical trial. J Rheumatol 2008;35:466\u2013468.","journal-title":"Analysis from a scleroderma clinical trial. J Rheumatol"},{"key":"2954_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s11655-015-2093-6","volume":"22","author":"L Wan","year":"2016","unstructured":"Wan L, Liu J, Huang CB, Wang Y, Chen X, Zhang WD, et al. Xinfeng Capsule for the treatment of rheumatoid arthritis patients with decreased pulmonary function\u2014a randomized controlled clinical trial. Chin J Integr Med 2016;22:168\u2013176.","journal-title":"Chin J Integr Med"},{"key":"2954_CR27","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/acr.21716","volume":"64","author":"C Muangchan","year":"2012","unstructured":"Muangchan C, Harding S, Khimdas S, Bonner A, Baron M, Pope J. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group. Arthritis Care Res (Hoboken) 2012;64:1405\u20131414.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2954_CR28","first-page":"26","volume":"3","author":"H Yang","year":"2014","unstructured":"Yang H, Lyu J, Huang LP, Yan YL, He XP. Effects of safflower decoction on the expression of skin vascular endothelial growth factor in mouse with scleroderma. Rheumat Arthritis (Chin) 2014;3:26\u201330.","journal-title":"Rheumat Arthritis (Chin)"},{"key":"2954_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12906-016-1056-6","volume":"16","author":"L Han","year":"2016","unstructured":"Han L, Bian H, Ouyang J, Bi Y, Yang L, Ye S. Wenyang Huazhuo Tongluo Formula, a Chinese herbal decoction, improves skin fibrosis by promoting apoptosis and inhibiting proliferation through down-regulation of survivin and cyclin D1 in systemic sclerosis. BMC Complement Altern Med 2016;16:69.","journal-title":"BMC Complement Altern Med"},{"key":"2954_CR30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1472-6882-14-224","volume":"14","author":"T Wu","year":"2014","unstructured":"Wu T, Chu H, Tu W, Song M, Chen D, Yuan J, et al. Dissection of the mechanism of traditional Chinese medical prescription\u2014Yiqihuoxue formula as an effective antifibrotic treatment for systemic sclerosis. BMC Complement Altern Med 2014;14:224.","journal-title":"BMC Complement Altern Med"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11655-017-2954-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-017-2954-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-017-2954-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T15:51:57Z","timestamp":1524757917000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11655-017-2954-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,15]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["2954"],"URL":"https:\/\/doi.org\/10.1007\/s11655-017-2954-2","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,15]]}}}